RxDoctor Payments Data

Jennifer Lillemon, MD

Urogynecology and Reconstructive Pelvic Surgery · Boise, IDNPI 1467718932

Payments from drug & device makers

$3,712in general payments, 2019–2025

Across 60 payments — averaging $61.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$2K
  • Boston Scientific$276
  • Caldera Medical, Inc$243
  • AbbVie$207
  • Axonics, Inc.$172
  • Bolton Medical Inc$144
  • plus $263 from 7 others

What the payments were for

  • Travel & lodging$1,82249%
  • Food & beverage$1,80049%
  • Education$892%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medtronic(2 entities)22$2,407
Boston Scientific7$276
Caldera Medical, Inc5$243
AbbVie(2 entities)8$207
Axonics, Inc.7$172
Bolton Medical Inc1$144
Johnson & Johnson3$64
BD1$50
Laborie Medical Technologies Corp.2$46
Avanos Medical1$30
180 Medical, Inc.1$29
Therapeuticsmd, Inc.1$23
Abbott1$21

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few urogynecology and reconstructive pelvic surgery providers in Idahoto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$85,531
Medicare patients
157
Services billed
715

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol175$13,578
Tolterodine Tartrate ErTolterodine Tartrate11$1,379
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst19$102
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim15$30

Paid to pharmacies, not to this prescriber.

Other urogynecology and reconstructive pelvic surgery in Boise

Where these figures come from

Is this you, or does something look wrong? →